Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03308578 · ClinicalTrials.gov registry record · Phase 1
Statins and CPAP in Adipose Tissue of OSA
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT03308578: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03308578 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03308578, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is aimed at examining the alterations in adipose tissue in obstructive sleep apnea (OSA) patients in response to treatment with atorvastatin in continuation with standard treatment with continuous positive airway pressure (CPAP).
Interventions
- DRUG Placebo oral capsule
- DRUG Atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2023-12-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03308578
The ClinicalTrials.gov registry entry for NCT03308578 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03308578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03308578 about?
NCT03308578 is a clinical study titled "Statins and CPAP in Adipose Tissue of OSA". This study is aimed at examining the alterations in adipose tissue in obstructive sleep apnea (OSA) patients in response to treatment with atorvastatin in continuation with standard treatment with continuous positive airway pressure (CPAP).
What is the current status of trial NCT03308578?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2018-01-08. Estimated completion is 2023-12-12.
What interventions are being tested in trial NCT03308578?
The interventions under investigation include: Placebo oral capsule (DRUG), Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT03308578?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.